About 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one
2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one (PubChem CID 44553889) has the molecular formula C36H39N7O4
and a molecular weight of 633.75 g/mol. Its IUPAC name is 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one.
Molecular Properties
| Compound Name | 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one |
| PubChem CID | 44553889 |
| Molecular Formula | C36H39N7O4 |
| Molecular Weight | 633.75 g/mol |
| Exact Mass | 633.31 |
| IUPAC Name | 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one |
| SMILES | CC(=O)N1CCN(c2ccc(Nc3cc(-c4cccc(-n5ncc6cc(C(C)(C)C)ccc6c5=O)c4CO)cn(C)c3=O)nc2)CC1 |
| InChI | InChI=1S/C36H39N7O4/c1-23(45)41-13-15-42(16-14-41)27-10-12-33(37-20-27)39-31-18-25(21-40(5)35(31)47)28-7-6-8-32(30(28)22-44)43-34(46)29-11-9-26(36(2,3)4)17-24(29)19-38-43/h6-12,17-21,44H,13-16,22H2,1-5H3,(H,37,39) |
| InChIKey | CQDGSIHMJQFSMI-UHFFFAOYSA-N |
| XLogP | 4.35 |
| TPSA | 125.59 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 633.75 |
| LogP ≤ 5 | 4.35 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Analyze 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one?
The IUPAC name of 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one (CID 44553889) is 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one.
What is the SMILES notation for 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one?
The canonical SMILES for 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one is CC(=O)N1CCN(c2ccc(Nc3cc(-c4cccc(-n5ncc6cc(C(C)(C)C)ccc6c5=O)c4CO)cn(C)c3=O)nc2)CC1.
What is the InChIKey of 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one?
The InChIKey is CQDGSIHMJQFSMI-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H39N7O4/c1-23(45)41-13-15-42(16-14-41)27-10-12-33(37-20-27)39-31-18-25(21-40(5)35(31)47)28-7-6-8-32(30(28)22-44)43-34(46)29-11-9-26(36(2,3)4)17-24(29)19-38-43/h6-12,17-21,44H,13-16,22H2,1-5H3,(H,37,39).
What are the key properties of 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one?
2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one has a molecular weight of 633.75 g/mol, XLogP of 4.35, 6 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[5-[[5-(4-acetylpiperazin-1-yl)-2-pyridinyl]amino]-1-methyl-6-oxo-3-pyridinyl]-2-(hydroxymethyl)phenyl]-6-tert-butylphthalazin-1-one is sourced from PubChem (CID 44553889), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).